Amanote Research

Amanote Research

    RegisterSign In

Sub-Macular Injection of Ranibizumab as a New Surgical Treatment for Refractory Diabetic Macular Edema

Case Medical Research
doi 10.31525/ct1-nct03975088
Full Text
Open PDF
Abstract

Available in full text

Date

June 5, 2019

Authors

Unknown

Publisher

Case Journals


Related search

Surgical Cystotomy for Refractory Diabetic Cystoid Macular Edema

Clinical Ophthalmology
Ophthalmology
2018English

Association of Changes in Macular Perfusion With Ranibizumab Treatment for Diabetic Macular Edema

JAMA Ophthalmology
Ophthalmology
2018English

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

Ophthalmology
Ophthalmology
2016English

New Strategies for Treatment of Diabetic Macular Edema

Journal of Ophthalmology
Ophthalmology
2018English

Efficacy of Sub-Tenon’s Capsule Injection of Triamcinolone Acetonide for Refractory Diabetic Macular Edema After Vitrectomy

Journal of Medical Investigation
BiochemistryMedicineGeneticsMolecular Biology
2008English

Intravitreal Ranibizumab for Diabetic Macular Edema With Prompt Versus Deferred Laser Treatment

Ophthalmology
Ophthalmology
2012English

Macular Edema Surgical Treatment

2012English

The Macular Function and Structure in Patients With Diabetic Macular Edema Before and After Ranibizumab Treatment

Documenta Ophthalmologica
OphthalmologySensory SystemsPhysiology
2016English

Ranibizumab in the Treatment of Patients With Visual Impairment Due to Diabetic Macular Edema

Clinical Ophthalmology
Ophthalmology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy